Trinity Biotech (TRIB) Reports In-Line Q3 EPS

Trinity Biotech (NASDAQ: TRIB) reported Q3 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $26.1 million versus the consensus estimate of $26.5 million.

For earnings history and earnings-related data on Trinity Biotech (TRIB) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance
• Raymond James Starts Old National Bancorp (ONB) at Market Perform